ME — 23andMe Holding Co. Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for 23andMe Holding Co., fiscal year end - March 31st, millions except per share.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:		PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash
Cash and Short Term Investments	—	208	282	553	387
Net Total Accounts Receivable
Net Total Receivables	—	6.39	2.48	3.38	1.9
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	253	314	602	425
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	138	124	105	94.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	—	405	452	1,152	943
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	—	139	122	153	149
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	270	210	236	229
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	—	134	242	916	714
Total Liabilities & Shareholders' Equity	—	405	452	1,152	943
Total Common Shares Outstanding
Total Preferred Shares Outstanding